vs

Side-by-side financial comparison of Valaris Ltd (VAL) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Valaris Ltd is the larger business by last-quarter revenue ($5.2M vs $3.8M, roughly 1.4× Vivos Therapeutics, Inc.). Valaris Ltd runs the higher net margin — 13798.1% vs -180.3%, a 13978.3% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs 3.4%). Vivos Therapeutics, Inc. produced more free cash flow last quarter ($-5.3M vs $-34.1M). Over the past eight quarters, Valaris Ltd's revenue compounded faster (29.5% CAGR vs 5.8%).

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

VAL vs VVOS — Head-to-Head

Bigger by revenue
VAL
VAL
1.4× larger
VAL
$5.2M
$3.8M
VVOS
Growing faster (revenue YoY)
VAL
VAL
+402.5% gap
VAL
405.9%
3.4%
VVOS
Higher net margin
VAL
VAL
13978.3% more per $
VAL
13798.1%
-180.3%
VVOS
More free cash flow
VVOS
VVOS
$28.8M more FCF
VVOS
$-5.3M
$-34.1M
VAL
Faster 2-yr revenue CAGR
VAL
VAL
Annualised
VAL
29.5%
5.8%
VVOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
VAL
VAL
VVOS
VVOS
Revenue
$5.2M
$3.8M
Net Profit
$717.5M
$-6.9M
Gross Margin
-7850.0%
78.1%
Operating Margin
-166.8%
Net Margin
13798.1%
-180.3%
Revenue YoY
405.9%
3.4%
Net Profit YoY
436.6%
-143.8%
EPS (diluted)
$10.13
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VAL
VAL
VVOS
VVOS
Q4 25
$5.2M
$3.8M
Q3 25
$5.6M
$6.8M
Q2 25
$700.0K
$3.8M
Q1 25
$3.0M
Q4 24
$-1.7M
$3.7M
Q3 24
$3.9M
$3.9M
Q2 24
$4.8M
$4.1M
Q1 24
$2.6M
$3.4M
Net Profit
VAL
VAL
VVOS
VVOS
Q4 25
$717.5M
$-6.9M
Q3 25
$188.1M
$-5.4M
Q2 25
$115.1M
$-5.0M
Q1 25
$-3.9M
Q4 24
$133.7M
$-2.8M
Q3 24
$64.6M
$-2.6M
Q2 24
$149.6M
$-1.9M
Q1 24
$25.5M
$-3.8M
Gross Margin
VAL
VAL
VVOS
VVOS
Q4 25
-7850.0%
78.1%
Q3 25
-7142.9%
58.0%
Q2 25
-56428.6%
55.2%
Q1 25
50.0%
Q4 24
24529.4%
56.7%
Q3 24
-11748.7%
60.5%
Q2 24
-9039.6%
65.4%
Q1 24
-17007.7%
56.7%
Operating Margin
VAL
VAL
VVOS
VVOS
Q4 25
-166.8%
Q3 25
-69.8%
Q2 25
-127.4%
Q1 25
-129.9%
Q4 24
-75.9%
Q3 24
-68.5%
Q2 24
-47.8%
Q1 24
-110.7%
Net Margin
VAL
VAL
VVOS
VVOS
Q4 25
13798.1%
-180.3%
Q3 25
3358.9%
-79.6%
Q2 25
16442.9%
-131.2%
Q1 25
-128.1%
Q4 24
-7864.7%
-76.4%
Q3 24
1656.4%
-67.8%
Q2 24
3116.7%
-47.6%
Q1 24
980.8%
-110.1%
EPS (diluted)
VAL
VAL
VVOS
VVOS
Q4 25
$10.13
$-0.58
Q3 25
$2.65
$-0.49
Q2 25
$1.61
$-0.55
Q1 25
$-0.45
Q4 24
$1.86
$0.41
Q3 24
$0.88
$-0.40
Q2 24
$2.03
$-0.60
Q1 24
$0.35
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VAL
VAL
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$599.4M
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$3.2B
$-1.5M
Total Assets
$5.3B
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VAL
VAL
VVOS
VVOS
Q4 25
$599.4M
$2.0M
Q3 25
$662.7M
$3.1M
Q2 25
$503.4M
$4.4M
Q1 25
$2.3M
Q4 24
$368.2M
$6.3M
Q3 24
$379.3M
$6.3M
Q2 24
$398.3M
$6.9M
Q1 24
$494.1M
$2.6M
Total Debt
VAL
VAL
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
VAL
VAL
VVOS
VVOS
Q4 25
$3.2B
$-1.5M
Q3 25
$2.4B
$2.5M
Q2 25
$2.3B
$4.6M
Q1 25
$4.4M
Q4 24
$2.2B
$8.0M
Q3 24
$2.1B
$7.7M
Q2 24
$2.2B
$6.3M
Q1 24
$2.0B
$582.0K
Total Assets
VAL
VAL
VVOS
VVOS
Q4 25
$5.3B
$25.2M
Q3 25
$4.6B
$25.6M
Q2 25
$4.5B
$26.0M
Q1 25
$11.3M
Q4 24
$4.4B
$15.3M
Q3 24
$4.3B
$15.3M
Q2 24
$4.4B
$15.8M
Q1 24
$4.4B
$11.8M
Debt / Equity
VAL
VAL
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VAL
VAL
VVOS
VVOS
Operating Cash FlowLast quarter
$72.2M
$-3.8M
Free Cash FlowOCF − Capex
$-34.1M
$-5.3M
FCF MarginFCF / Revenue
-655.8%
-139.7%
Capex IntensityCapex / Revenue
2044.2%
40.0%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$159.9M
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VAL
VAL
VVOS
VVOS
Q4 25
$72.2M
$-3.8M
Q3 25
$198.1M
$-4.2M
Q2 25
$120.0M
$-3.5M
Q1 25
$-3.8M
Q4 24
$124.6M
$-2.9M
Q3 24
$193.0M
$-4.2M
Q2 24
$11.5M
$-3.0M
Q1 24
$26.3M
$-2.5M
Free Cash Flow
VAL
VAL
VVOS
VVOS
Q4 25
$-34.1M
$-5.3M
Q3 25
$128.3M
$-4.2M
Q2 25
$52.8M
$-4.3M
Q1 25
$-3.9M
Q4 24
$12.9M
$-3.1M
Q3 24
$111.1M
$-4.4M
Q2 24
$-98.7M
$-3.1M
Q1 24
$-125.0M
$-2.7M
FCF Margin
VAL
VAL
VVOS
VVOS
Q4 25
-655.8%
-139.7%
Q3 25
2291.1%
-62.6%
Q2 25
7542.9%
-111.6%
Q1 25
-129.9%
Q4 24
-758.8%
-84.0%
Q3 24
2848.7%
-113.4%
Q2 24
-2056.3%
-76.7%
Q1 24
-4807.7%
-78.0%
Capex Intensity
VAL
VAL
VVOS
VVOS
Q4 25
2044.2%
40.0%
Q3 25
1246.4%
1.2%
Q2 25
9600.0%
20.2%
Q1 25
4.0%
Q4 24
-6570.6%
4.5%
Q3 24
2100.0%
5.0%
Q2 24
2295.8%
1.5%
Q1 24
5819.2%
4.4%
Cash Conversion
VAL
VAL
VVOS
VVOS
Q4 25
0.10×
Q3 25
1.05×
Q2 25
1.04×
Q1 25
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VAL
VAL

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons